Panadol Extra optizorb Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

panadol extra optizorb

glaxosmithkline dungarvan limited - paracetamolis/kofeinas - plėvele dengtos tabletės - 500 mg/65 mg - paracetamol, combinations excl. psycholeptics

Puri-Nethol Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

puri-nethol

aspen pharma trading limited - merkaptopurino monohidratas - tabletės - 50 mg - mercaptopurine

Imuran Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

imuran

aspen pharma trading limited - azatioprinas - plėvele dengtos tabletės - 50 mg - azathioprine

Myleran Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

myleran

aspen pharma trading limited - busulfanas - plėvele dengtos tabletės - 2 mg - busulfan

Alymsys Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

alymsys

mabxience research sl - bevacizumabas - colorectal neoplasms; breast neoplasms; ovarian neoplasms; peritoneal neoplasms; carcinoma, non-small-cell lung; carcinoma, renal cell; uterine cervical neoplasms - antinavikiniai vaistai - alymsys in combination with fluoropyrimidine based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. alymsys in combination with paclitaxel is indicated for first line treatment of adult patients with metastatic breast cancer. alymsys in combination with capecitabine is indicated for first line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. patients who have received taxane and anthracycline containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with alymsys in combination with capecitabine. alymsys, in addition to platinum based chemotherapy, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non small cell lung cancer other than predominantly squamous cell histology. alymsys, in combination with erlotinib, is indicated for first line treatment of adult patients with unresectable advanced, metastatic or recurrent non squamous non small cell lung cancer with epidermal growth factor receptor (egfr) activating mutations. alymsys in combination with interferon alfa 2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer. alymsys, in combination with carboplatin and paclitaxel is indicated for the front line treatment of adult patients with advanced (international federation of gynecology and obstetrics (figo) stages iii b, iii c and iv) epithelial ovarian, fallopian tube, or primary peritoneal cancer. alymsys, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other vegf inhibitors or vegf receptor targeted agents. alymsys, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.

Tygacil Europos Sąjunga - lietuvių - EMA (European Medicines Agency)

tygacil

pfizer europe ma eeig - tigecycline - bacterial infections; skin diseases, bacterial; soft tissue infections - antibacterials sisteminio naudojimo, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antibakterinių veiksnių. tinkamas naudoti antibakterinių veiksnių.

MICRO 10 EXCEL Lietuva - lietuvių - Ecolab

micro 10 excel

ecolab deutschland gmbh -

Oxivir Excel Foam. Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

oxivir excel foam.

diversey polska sp. z o.o., al. jerozolimskie 134, pl-02305 warszawa (lenkija). - vandenilio peroksidas - veikliosios medžiagos cas nr.: 7722-84-1, eb nr.: 231-765-0, veikliosios medžiagos pavadinimas: vandenilio peroksidas, koncentracija: 0.36% , veiklioji

Oxivir Excel Wipe. Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

oxivir excel wipe.

diversey polska sp. z o.o., al. jerozolimskie 134, pl-02305 warszawa (lenkija). - vandenilio peroksidas - veikliosios medžiagos cas nr.: 7722-84-1, eb nr.: 231-765-0, veikliosios medžiagos pavadinimas: vandenilio peroksidas, koncentracija: 0.36% , veiklioji

Wip’Anios Excel. Lietuva - lietuvių - SMCA (Valstybinė vaistų kontrolės tarnyba)

wip’anios excel.

ecolab sp.z o.o., ul. opolska 114, pl-31323 krakow (lenkija). - didecildimetilamonio chloridas - veikliosios medžiagos cas nr.: 7173-51-5, eb nr.: 230-525-2, veikliosios medžiagos pavadinimas: didecildimetilamonio chloridas, koncentracija: 0.3% , veiklioji